Skip to main content

Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia

Buy Article:

$48.00 plus tax (Refund Policy)

Abstract:

Williams R, Kopala L, Malla A, Smith G, Love L, Balshaw R. Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia.

Acta Psychiatr Scand 2006: 113 (Suppl. 430): 12–21. © 2006 Blackwell Munksgaard. Objective: 

To evaluate over a 2-year period, patients from academic/non-academic centres, from each region of Canada, to determine whether location or other variables such as medication type, gender or income was associated with outcome as defined by non-hospitalization and persistence on original treatment. Method: 

A total of 448 patients were recruited from academic and non-academic centres across all provinces of Canada and followed up for 2 years. Results: 

Patients from British Columbia had significantly lower rates of hospitalization than patients from other provinces. Male patients showed greater symptomatic improvement at 2 years from initial assessment compared to females. Patients on clozapine, risperidone and olanzapine were least likely to be hospitalized. Conclusion: 

There were some regional differences noted in both utilization of types of antipsychotic medications and hospitalization rates. In this sample of stable out-patients over 70% who started on monotherapy with clozapine, risperidone, olanzapine and quetiapine remained on the same medication over the 2-year study period.

Keywords: Canada; hospitalization; outcome assessment; schizophrenia

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0447.2006.00757.x

Affiliations: 1: Department of Psychiatry, University of British Columbia, Vancouver, BC 2: Department of Psychiatry, McGill University, Montreal, QC 3: Syreon Corporation, Vancouver, BC, Canada

Publication date: May 1, 2006

mksg/acp/2006/00000113/A430s430/art00003
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more